Research Article
Safety of 3 Tesla Magnetic Resonance Imaging in Patients with Sickle Cell Disease
Table 1
Sickle cell disease (SCD) participant demographics and percentage with acute, overt, and silent stroke.
| | | Female | Male | Combined |
| | Mean age (range) (years) | 19 (6–44) | 20 (6–37) | 19.6 (6–44) | | Total number of participants | 90 (52.3) | 82 (47.7) | 172 | | Number of adults ≥18 years (percent) | 43 (47.8) | 48 (58.5) | 91 (52.9) | | Number of children <18 years (percent) | 47 (52.2) | 34 (41.5) | 81 (47.1) | | Total hematocrit (range) (percent) | 26.1 (15–36) | 26.7 (17–35) | 25.8 (15–36) | | Number with acute infarct present (percent) | 0 | 0 | 0 | | Number with chronic silent infarct present (percent) | 32 (35.6) | 44 (53.7) | 76 (44.2) | | Number with chronic overt stroke present (percent) | 14 (15.6) | 9 (11.0) | 23 (13.4) | | Number with vasculopathy present (percent) | 9 (10.0) | 7 (8.5) | 16 (8.5) | | Number with HbSS phenotype (percent) | 77 (85.6) | 74 (90.2) | 151 (87.8) | | Number with HbSβ0 phenotype (percent) | 10 (11.1) | 7 (8.5) | 17 (9.9) | | Number with HbSC phenotype (percent) | 3 (3.3) | 1 (1.2) | 4 (2.3) |
|
|
